Sinsin Pharmaceutical Co., Ltd

KOSDAQ:A002800 株式レポート

時価総額：₩78.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Sinsin Pharmaceutical マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Ki Lee Byoung

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権0.3%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

Mar 20
Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Mar 06
What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

Feb 08
Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

Jan 18
If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

Dec 25
We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

Nov 29
What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

CEO（最高経営責任者

Ki Lee Byoung

no data

在職期間

Ki Lee Byoung is President & CEO of Sinsin Pharmaceutical Co., Ltd.